Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical: heparin substance granted orphan-drug designation by FDA

May 4 (Reuters) - CORLINE BIOMEDICAL AB  CLBIO.ST  
    * NOTIFIED BY US FOOD AND DRUG ADMINISTRATION, FDA, THAT THE 
COMPANY'S HEPARIN SUBSTANCE HAS BEEN GRANTED ORPHAN-DRUG 
DESIGNATION IN THE UNITED STATES 
 
Source text for Eikon:  ID:nGNE6bGwwr  
Further company coverage:  CLBIO.ST  
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com;))

Recent news on Corline Biomedical AB

See all news